Author Question: When developing the plan of care for a client who is to receive aggressive drug therapy for ... (Read 145 times)

sammy

  • Hero Member
  • *****
  • Posts: 818
When developing the plan of care for a client who is to receive aggressive drug therapy for treatment of HIV, the nurse understands that the goal of this therapy is to:
 
  A) promote progression of disease C) improve survival rates
  B) intervene in late-stage AIDS D) conduct more drug research

Question 2

After the nurse teaches a client about measures to help reduce the symptoms of premenstrual syndrome, which client statement indicates a need for additional teaching?
 
  A) I will make sure to take my estrogen supplements a week before my period.
  B) I've signed up to join an aerobic exercise class three times a week.
  C) I'll cut down on the number of cups of coffee and colas that I drink everyday.
  D) I've just quit smoking about a month ago, so that should help.



stillxalice

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

C

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

Although not all of the following muscle groups are commonly used, intramuscular injections may be given into the abdominals, biceps, calves, deltoids, gluteals, laterals, pectorals, quadriceps, trapezoids, and triceps.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

About 600,000 particles of skin are shed every hour by each human. If you live to age 70 years, you have shed 105 pounds of dead skin.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library